Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 2	2024-06-10		NCT05720260

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Taiwan University Hospital	540

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Oncology, National Taiwan University Hospital	Taipei	Taiwan	1

Clinical trials